| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Republic of Korea | 4 | |
| #2 | WIPO (World Intellectual Property Organization) | 3 | |
| #3 | EPO (European Patent Office) | 2 | |
| #4 | United States | 2 | |
| #5 | China | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Unspecified technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Choi Sangdun | 7 |
| #2 | Kwon Hyuk Kwon | 5 |
| #3 | Shin Hyeon Jun | 5 |
| #4 | Achek Asma | 4 |
| #5 | Choi Sang Dun | 4 |
| #6 | Gui Xiangai | 3 |
| #7 | Shah Masaud | 2 |
| #8 | Gui Xiang Ai | 2 |
| #9 | Park Seol Hee | 2 |
| #10 | Suh Chang Hee | 2 |
| Publication | Filing date | Title |
|---|---|---|
| WO2019209030A1 | Tlr4 antagonistic peptide | |
| KR20200084569A | Peptide Inhibiting TLR4 Signaling Pathway and Uses Thereof | |
| KR20200050715A | Composition for preventing or treating lupus comprising tlr-inhibiting peptides | |
| KR20180122940A | Peptide for inhibiting toll-like receptors and pharmaceutical composition comprising the same |